Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease

Parasite Immunology

Volumn 32, Issue 3, 2010, Pages 202-208

  De Paula Costa, G ^a   Silva, R R ^a   Pedrosa, M C ^a   Pinho, V ^b   De Lima, W G ^a   Teixeira, M M ^b   Bahia, M T ^a   Talvani, A ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cytokines; Enalapril; Heart inflammation; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; CYTOCHROME P450; CYTOKINE; ENALAPRIL MALEATE; GAMMA INTERFERON; NITRIC OXIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL INFILTRATION; CHAGAS DISEASE; CONTROLLED STUDY; DRUG EFFECT; HEART; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CYTOKINES; ENALAPRIL; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; SERUM; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 76749108060     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01179.x     Document Type: Article

References (30)

1. Rocha MO, Teixeira MM Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007 5 : 727 743.
2. Bestetti RB, Theodoropoulos TA, Cardinalli-Neto A Cury PM. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy. Am Heart J 2008 156 : 422 430.
3. Ferrario CM Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006 98 : 121 128.
4. Sciarretta S, Paneni F, Palano F, et al. Role of the renin-angiotensin- aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci (Lond) 2009 116 : 467 477.
5. MacFadyen RJ, Meredith PA Elliott HL. Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. Clin Pharmacokinet 1993 25 : 274 282.
6. Kazi D Deswal A. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin 2008 26 : 1 14.
7. Enseleit F, Hurlimann D Luscher TF. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J Cardiovasc Pharmacol 2001 37 : 21 30. (Pubitemid 32480429)
8. Leon JS, Wang K Engman DM. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 2003 107 : 2264 2269.
9. Rezkalla S, Kloner RA, Khatib G Khatib R. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation 1990 81 : 1039 1046. (Pubitemid 20090403)
10. Araki M, Kanda T, Imai S, Suzuki T, Murata K Kobayashi I. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. J Cardiovasc Pharmacol 1995 26 : 61 65.
11. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1962 4 : 389 396.
12. da Cunha V, Tham DM, Martin-McNulty B, et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 2005 178 : 9 17.
13. Falcao PL, Correa-Oliveira R, Fraga LA, et al. Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. J Infect Dis 2002 186 : 1696 1700.
14. Caldas IS, Talvani A, Caldas S, et al. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol Res 2008 103 : 413 421.
15. Talvani A, Ribeiro CS, Aliberti JCS, et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2000 2 : 851 866.
16. Botoni FA, Poole-Wilson PA, Ribeiro AL, et al. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J 2007 154 : 544-e1 8.
17. Marino AP, da Silva A, dos Santos P, et al. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 2004 110 : 1443 1449.
18. Talvani A, Rocha MO, Cogan J, et al. Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 2004 99 : 645 649.
19. Talvani A, Rocha MO, Cogan J, et al. Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia. Int J Cardiol 2005 100 : 503 504.
20. Suzuki Y, Gómez-Guerrero C, Shirato I, et al. Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway. J Immunol 2002 169 : 4136 4146.
21. Jurima-Romet M, Huang HS, Paul CJ Thomas BH. Enalapril cytotoxicity in primary cultures of rat hepatocytes - effects of cytochrome P450 inducers and inhibitors. Toxicol Lett 1991 58 : 257 267.
22. Docampo R. Sensitivity of parasites to free radical damage by antiparasitic drugs. Chem Biol 1990 73 : 1 27.
23. Krauth-Siegel RL, Meiering SK Schmidt H. The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania. Biol Chem 2003 384 : 539 549.
24. Ghazi-Khansari M, Mohammadi-Bardbori A Hosseini MJ. Using Janus green B to study paraquat toxicity in rat liver mitochondria: role of ACE inhibitors (thiol and nonthiol ACEi). Ann N Y Acad Sci 2006 1090 : 98 107.
25. Almeida HO, Pereira FE Tafuri WL. Mast cells in Chagas'chronic cardiopathy. Rev Inst Med Trop Sao Paulo 1975 17 : 5 9.
26. Postan M, Correa R, Ferrans VJ Tarleton RL. In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi. Int Arch Allergy Immunol 1994 105 : 251 257.
27. Meuser-Batista M, Correa JR, Soares MJ Henriques-Pons A. Isolation of cardiac mast cells in experimental Trypanosoma cruzi infection. Tissue Cell 2008 40 : 309 316.
28. Miyazaki M, Takai S, Jin D Muramatsu M. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacol Ther 2006 112 : 668 676.
29. Wawrocka-Pawlak M Dabrowski R. The effect of captopril on histamine release from purified rat mast cells. Inflamm Res 1999 48 : 262 264.
30. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007 7 : 337 341.